<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 21 Apr 2026 08:55:15 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/genericharvoni/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[MyHep-LVIR Tablets : MyLan's Generic Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C]]></title><description><![CDATA[• Brand Name : MyHep-LVIR • Active Ingredient : Ledipasvir 90 mg & Sofosbuvir 400 mg • Manufacturer Company : Mylan Pharmaceutical • Packaging Size : Pack of 28 Tablets • Route of Administration :]]></description><link>http://direct.ecency.com/genericharvoni/@drugssquare/myhep-lvir-tablets-mylan-s-generic-harvoni-achieves-96-cure-rate-in-patients-with-hepatitis-c</link><guid isPermaLink="true">http://direct.ecency.com/genericharvoni/@drugssquare/myhep-lvir-tablets-mylan-s-generic-harvoni-achieves-96-cure-rate-in-patients-with-hepatitis-c</guid><category><![CDATA[genericharvoni]]></category><dc:creator><![CDATA[drugssquare]]></dc:creator><pubDate>Mon, 16 Apr 2018 06:56:27 GMT</pubDate><enclosure url="https://images.ecency.com/p/99pyU5Ga1kws91ecJjkANAzfstp5ietJ4ACvk9NVLh4djJJHKP57h6qirXwHvifDY3YWtxDfPPX9znsoCjeftiT2mnJm4RRyZToxqq1DKCBDihUPEPKiMBwPWPKzxYsM1x?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>